Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) Operating Income (2016 - 2026)

Champions Oncology has reported Operating Income over the past 17 years, most recently at -$276000.0 for Q1 2026.

  • Quarterly results put Operating Income at -$276000.0 for Q1 2026, down 106.13% from a year ago — trailing twelve months through Jan 2026 was -$2.6 million (down 141.74% YoY), and the annual figure for FY2025 was $4.6 million, up 161.9%.
  • Operating Income for Q1 2026 was -$276000.0 at Champions Oncology, down from $185000.0 in the prior quarter.
  • Over the last five years, Operating Income for CSBR hit a ceiling of $4.5 million in Q1 2025 and a floor of -$2.6 million in Q1 2024.
  • Median Operating Income over the past 5 years was -$284000.0 (2022), compared with a mean of -$479823.5.
  • Biggest five-year swings in Operating Income: plummeted 28028.57% in 2023 and later surged 274.58% in 2025.
  • Champions Oncology's Operating Income stood at $7000.0 in 2022, then plummeted by 28028.57% to -$2.0 million in 2023, then surged by 137.44% to $732000.0 in 2024, then plummeted by 74.73% to $185000.0 in 2025, then tumbled by 249.19% to -$276000.0 in 2026.
  • The last three reported values for Operating Income were -$276000.0 (Q1 2026), $185000.0 (Q4 2025), and -$527000.0 (Q3 2025) per Business Quant data.